Real Attorneys. Real People. Real Results.
Real Attorneys. Real People. Real Results.
The U.S. Food and Drug Administration has announced that all prescription and over-the-counter ranitidine (Zantac) drugs should be removed from the market immediately. The push to fully remove this drug from the market is part of an on-going investigation by the FDA of a contaminant known as NDMA, a probable human carcinogen. Continue Reading FDA Requests Removal of Ranitidine (Zantac)
On September 13th, the Food and Drug Administration announced that some ranitidine medications contained low-levels of a possible carcinogen called nitrosodimethylamine (NDMA). Those drugs that contain NDMA include heartburn medication Zantac, and its generic forms.…
Macleods Pharmaceuticals has initiated a voluntary recall of 32 lots of Losartan Potassium USP Tablets and Losartan Potassium/Hydrochlorothiazide combination Tablets. The recall was initiated after trace amounts of an unexpected impurity were found in a…
The Essure implant, the controversial device used as a form of permanent birth control by over 750,000 women, was recently taken off the market by its manufacturer, Bayer. Thousands of women have accused the device of causing…
Forester Haynie is investigating Valsartan cases involving Stomach cancer, Kidney cancer, Intestinal cancer, Liver cancer, Bladder cancer, & Pancreatic cancer. Continue Reading Prescription Drug Valsartan Recall
